|
Video: What is a Stock Split?
|
|
Axcella Health is a clinical-stage biotechnology company focused on an approach to treat diseases using compositions of endogenous metabolic modulators. Co.'s pipeline includes main therapeutic candidates for the treatment of Long COVID associated fatigue, and for the treatment of non-alcoholic steatohepatitis (NASH). AXA1125 is being developed as a product candidate for the treatment of Long COVID. AXA1125 is an oral product candidate for the treatment of NASH. AXA1665 is a product candidate for the reduction in risk of Overt Hepatic Encephalopathy recurrence in adult patients with liver cirrhosis. According to our AXLA split history records, AXLA has had 1 split. | |
|
AXLA (AXLA) has 1 split in our AXLA split history database. The split for AXLA took place on September 19, 2023. This was a 1 for 25 reverse split, meaning for each 25 shares of AXLA owned pre-split, the shareholder now owned 1 share. For example, a 1000 share position pre-split, became a 40 share position following the split.
When a company such as AXLA conducts a reverse share split, it is usually because shares have fallen to a lower per-share pricepoint than the company would like. This can be important because, for example, certain types of mutual funds might have a limit governing which stocks they may buy, based upon per-share price. The $5 and $10 pricepoints tend to be important in this regard. Stock exchanges also tend to look at per-share price, setting a lower limit for listing eligibility. So when a company does a reverse split, it is looking mathematically at the market capitalization before and after the reverse split takes place, and concluding that if the market capitilization remains stable, the reduced share count should result in a higher price per share.
Looking at the AXLA split history from start to finish, an original position size of 1000 shares would have turned into 40 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into AXLA shares, starting with a $10,000 purchase of AXLA, presented on a split-history-adjusted basis factoring in the complete AXLA split history.
Growth of $10,000.00
Without Dividends Reinvested
|
Start date: |
05/10/2019 |
|
End date: |
11/29/2023 |
|
Start price/share: |
$348.00 |
|
End price/share: |
$1.00 |
|
Dividends collected/share: |
$0.00 |
|
Total return: |
-99.71% |
|
Average Annual Total Return: |
-72.30% |
|
Starting investment: |
$10,000.00 |
|
Ending investment: |
$28.73 |
|
Years: |
4.56 |
|
|
|
Date |
Ratio |
09/19/2023 | 1 for 25 |
|
|